A bottle of generic tablets produced by an Indian pharma firm. (Photographer: Dhiraj Singh/Bloomberg)

Q1 Results: Aurobindo Pharma Q1 Profit Falls Short Of Analysts Estimates

Aurobindo Pharma Ltd.’s profit in the quarter ended June missed analysts estimates.Net profit fell 12.1 percent from the year-ago period to Rs 456 crore, the drugmaker said in its exchange filing. ...

Bloomberg Quint

Add BloombergQuint App to Home screen.